Header Logo

Connection

Johanna Seddon to Prevalence

This is a "connection" page, showing publications Johanna Seddon has written about Prevalence.
Connection Strength

0.683
  1. Ferrara D, Seddon JM. Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration. JAMA Ophthalmol. 2015 Jul; 133(7):785-91.
    View in: PubMed
    Score: 0.092
  2. Sommerlad SF, Morton JM, Johnstone I, O'Leary CA, Seddon JM. Consequences of a screening programme on the prevalence of congenital hereditary sensorineural deafness in the Australian Cattle Dog. Anim Genet. 2014 Dec; 45(6):855-62.
    View in: PubMed
    Score: 0.088
  3. Sobrin L, Seddon JM. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res. 2014 May; 40:1-15.
    View in: PubMed
    Score: 0.083
  4. Ioannidis JP, Yu Y, Seddon JM. Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. Epidemiology. 2012 Nov; 23(6):902-9.
    View in: PubMed
    Score: 0.077
  5. Weiner DE, Tighiouart H, Reynolds R, Seddon JM. Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant. 2011 Oct; 26(10):3159-65.
    View in: PubMed
    Score: 0.068
  6. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009 May; 50(5):2044-53.
    View in: PubMed
    Score: 0.059
  7. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005 Mar; 123(3):321-7.
    View in: PubMed
    Score: 0.045
  8. Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int Ophthalmol Clin. 2004; 44(4):17-39.
    View in: PubMed
    Score: 0.042
  9. Kleinerman RA, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM. Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016. J Natl Cancer Inst. 2019 09 01; 111(9):961-969.
    View in: PubMed
    Score: 0.031
  10. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997 Feb; 123(2):199-206.
    View in: PubMed
    Score: 0.026
  11. Fong DS, Seddon JM. Diagnostic tests: an overview. Int Ophthalmol Clin. 1994; 34(3):187-95.
    View in: PubMed
    Score: 0.021
  12. Gragoudas ES, Egan KM, Saornil MA, Walsh SM, Albert DM, Seddon JM. The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology. 1993 Oct; 100(10):1555-9; discussion 1560.
    View in: PubMed
    Score: 0.020
  13. Jun JJ, Duker JS, Baumal CR, McCabe F, Reichel E, Rogers AH, Seddon JM, Tolentino FI. Cystoid macular edema without macular thickening: a retrospective optical coherence tomographic study. Retina. 2010 Jun; 30(6):917-23.
    View in: PubMed
    Score: 0.016
  14. Haan MN, Klein R, Klein BE, Deng Y, Blythe LK, Seddon JM, Musch DC, Kuller LH, Hyman LG, Wallace RB. Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study. Arch Ophthalmol. 2006 Jul; 124(7):988-92.
    View in: PubMed
    Score: 0.012
  15. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 1989 Dec; 96(12):1716-21.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.